Skip to main content
Top
Literature
1.
go back to reference Malyszko J, Durlik M, Przybylowski P (2009) Kidney dysfunction after non renal solid organ transplantation. Ann Transpl 14:71–79 Malyszko J, Durlik M, Przybylowski P (2009) Kidney dysfunction after non renal solid organ transplantation. Ann Transpl 14:71–79
2.
go back to reference Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N (2006) Continued influence of preoperative renal function on outcome of orthotropic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transpl 6:2651–2659CrossRef Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N (2006) Continued influence of preoperative renal function on outcome of orthotropic liver transplant (OLTX) in the US: Where will MELD lead us? Am J Transpl 6:2651–2659CrossRef
3.
go back to reference Pichler RH, Husky J, Kowalewska J, Moiz A, Perkins J, Davis CL, Leca N (2016) Kidney biopsies may help predict renal function after liver transplantation. Transplantation 100:2122–2128CrossRef Pichler RH, Husky J, Kowalewska J, Moiz A, Perkins J, Davis CL, Leca N (2016) Kidney biopsies may help predict renal function after liver transplantation. Transplantation 100:2122–2128CrossRef
4.
go back to reference Ziolkowski J, Paczek L, Senatorski G, Niewczas M, Oldakowska-Jedynak U, Wyzgal J et al (2003) Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transpl Proc 35:2307–2309CrossRef Ziolkowski J, Paczek L, Senatorski G, Niewczas M, Oldakowska-Jedynak U, Wyzgal J et al (2003) Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transpl Proc 35:2307–2309CrossRef
5.
go back to reference Axelsen RA, Crawford DH, Endre ZH, Lynch SV, Balderson GA, Strong RW, Fleming SJ (1995) Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 27:237–246CrossRef Axelsen RA, Crawford DH, Endre ZH, Lynch SV, Balderson GA, Strong RW, Fleming SJ (1995) Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation. Pathology 27:237–246CrossRef
6.
go back to reference McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ et al (2006) Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144:735–741CrossRef McGuire BM, Julian BA, Bynon JS Jr, Cook WJ, King SJ, Curtis JJ et al (2006) Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144:735–741CrossRef
7.
go back to reference Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD (2014) Chronic kidney disease and associated mortality after liver transplantation - a time-dependent analysis using measured glomerular filtration rate. J Hepatol 61:286–292CrossRef Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD (2014) Chronic kidney disease and associated mortality after liver transplantation - a time-dependent analysis using measured glomerular filtration rate. J Hepatol 61:286–292CrossRef
8.
go back to reference Moreno MJ, Cuervas-Mons V, Rubio E, Pons F, Herreros de TA. (2003) Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality. Transpl Proc 35:1907–1908CrossRef Moreno MJ, Cuervas-Mons V, Rubio E, Pons F, Herreros de TA. (2003) Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality. Transpl Proc 35:1907–1908CrossRef
9.
go back to reference Fujinaga K, Usui M, Yamamoto N, Ishikawa E, Nakatani A, Kishiwada M et al (2014) Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after liver living donor liver transplantation: significance of renal biopsy. Transpl Proc 46:804–810CrossRef Fujinaga K, Usui M, Yamamoto N, Ishikawa E, Nakatani A, Kishiwada M et al (2014) Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after liver living donor liver transplantation: significance of renal biopsy. Transpl Proc 46:804–810CrossRef
10.
go back to reference Lee JH, Cho YH, Ryu SJ, Kim SS, Lee YH, Jang IA et al (2013) Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment. Kidney Res Clin Pract 32:153–157CrossRef Lee JH, Cho YH, Ryu SJ, Kim SS, Lee YH, Jang IA et al (2013) Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment. Kidney Res Clin Pract 32:153–157CrossRef
Metadata
Title
Kidney biopsy in patients after liver transplantation: an underutilized, but clinically important procedure
Authors
Monika Wieliczko
Urszula Ołdakowska-Jedynak
Titus Andrian
Jolanta Małyszko
Publication date
01-06-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02432-y

Other articles of this Issue 6/2020

International Urology and Nephrology 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.